Cefpodoxime Proxetil & Bladder transitional cell carcinoma
100.0%
of users reported Bladder transitional cell carcinoma
58.6%
also reported Hospitalization
100.0%
are women
Most common medical consequences
Hospitalization
58.6%
Severe reaction
41.4%
Have you experienced any negative side effects from this medication?
Cefpodoxime Proxetil: general information
Most common side effects (1)
Most commonly affected ages
60 - 69 years
100.0%
Stay safe!
Get the latest drug safety information, personalized and delivered straight to your inbox